Kei Funakoshi

Mibu, 3210293, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Sustained Remission After Treatment with Rituximab in CIDP Without Nodal/Paranodal Antibodies.

Sustained Remission After Treatment with Rituximab in CIDP Without Nodal/Paranodal Antibodies.

Journal: Internal medicine (Tokyo, Japan)

Published: April 01, 2026

IgG subclass shifts occurring at acute exacerbations in autoimmune nodopathies.

IgG subclass shifts occurring at acute exacerbations in autoimmune nodopathies.

Journal: Journal of neurology

Published: June 15, 2024

Do corticosteroids aggravate pure motor chronic inflammatory demyelinating polyneuropathy?

Do corticosteroids aggravate pure motor chronic inflammatory demyelinating polyneuropathy?

Journal: Journal of the peripheral nervous system : JPNS

Published: April 17, 2024

Proteinuria is a key to suspect autoimmune nodopathies.

Proteinuria is a key to suspect autoimmune nodopathies.

Journal: European journal of neurology

Published: April 08, 2024

Associations between the burdens of comorbid sleep problems, central sensitization, and headache-related disability in patients with migraine.

Associations between the burdens of comorbid sleep problems, central sensitization, and headache-related disability in patients with migraine.

Journal: Frontiers in neurology

Published: January 20, 2024

Could efficacy at 1 week after galcanezumab administration for patients with migraine predict responders at 3 months? A real world study.

Could efficacy at 1 week after galcanezumab administration for patients with migraine predict responders at 3 months? A real world study.

Journal: Journal of neurology

Published: April 25, 2023

Additional Steroid Therapy for Delayed Facial Palsy in Miller Fisher Syndrome.

Additional Steroid Therapy for Delayed Facial Palsy in Miller Fisher Syndrome.

Journal: Internal medicine (Tokyo, Japan)

Published: November 17, 2022

A safe change from eculizumab to satralizumab in a patient with neuromyelitis optica spectrum disorder.

A safe change from eculizumab to satralizumab in a patient with neuromyelitis optica spectrum disorder.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: August 11, 2022

The Effect of Rotigotine on Cognitive Function, Daytime Sleepiness, and Sleep Problems in Parkinson Disease: An Open-Label Pilot Study.

The Effect of Rotigotine on Cognitive Function, Daytime Sleepiness, and Sleep Problems in Parkinson Disease: An Open-Label Pilot Study.

Journal: Clinical neuropharmacology

Published: May 17, 2022

Sleep-related hallucinations in patients with Parkinson's disease.

Sleep-related hallucinations in patients with Parkinson's disease.

Journal: PloS one

Published: October 05, 2021

Impact of the COVID-19 Pandemic on the Quality of Life of Patients with Parkinson's Disease and Their Caregivers: A Single-Center Survey in Tochigi Prefecture.

Impact of the COVID-19 Pandemic on the Quality of Life of Patients with Parkinson's Disease and Their Caregivers: A Single-Center Survey in Tochigi Prefecture.

Journal: Journal of Parkinson's disease

Published: March 29, 2021

Bickerstaff's Brainstem Encephalitis Suspected as Functional Neurologic Disorders.

Bickerstaff's Brainstem Encephalitis Suspected as Functional Neurologic Disorders.

Journal: International medical case reports journal

Published: February 14, 2020

Showing 1-12 of 16

Last Updated: 09/26/2026